Beclin 1 and p62 expression in non-small cell lung cancer: Relation with malignant behaviors and clinical outcome

International Journal of Clinical and Experimental Pathology

Volumn 8, Issue 9, 2015, Pages 10644-10652

  Wang, Xifeng ^a   Du, Ziyan ^a   Li, Lingyun ^a   Shi, Minhua ^a   Yu, Yong ^a  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

Author keywords

Autophagy; Beclin 1; Non small cell lung cancer; p62; Prognosis

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; BECLIN 1; BECN1 PROTEIN, HUMAN; MEMBRANE PROTEIN; SEQUESTOSOME 1; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN; TUMOR MARKER;

ADENOCARCINOMA; ADVERSE EFFECTS; AUTOPHAGY; CANCER STAGING; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NEOPLASMS; LYMPH NODE METASTASIS; MALE; METABOLISM; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SECONDARY; SMOKING; TIME FACTOR; TREATMENT OUTCOME; TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BECLIN-1; BIOMARKERS, TUMOR; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; CELL LINE, TUMOR; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; LYMPHATIC METASTASIS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SEQUESTOSOME-1 PROTEIN; SMOKING; TIME FACTORS; TREATMENT OUTCOME;

EID: 85013083724     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30.
2. Chen PL, Zhao T, Feng R, Chai J, Tong GX, Wang DB. Patterns and trends with cancer incidence and mortality rates reported by the China National Cancer Registry. Asian Pac J Cancer Prev 2014; 15: 6327-32.
3. Pattingre S, Espert L, Biard-Piechaczyk M, Codogno P. Regulation of macroautophagy by mTOR and Beclin 1 complexes. Biochimie 2008; 90: 313-23.
4. He C, Levine B. The Beclin 1 interactome. Curr Opin Cell Biol 2010; 22: 140-49.
5. Zhou W, Yue C, Deng J, Hu R, Xu J, Feng L, Lan Q, Zhang W, Ji D, Wu J, Liu Q, Liu A. Autophagic protein Beclin 1 serves as an independent positive prognostic biomarker for non-small cell lung cancer. Plos One 2013; 8: e80338.
6. He Y, Zhao X, Subahan NR, Fan L, Gao J, Chen H. The prognostic value of autophagy-related markers beclin-1 and microtubule-associated protein light chain 3B in cancers: a systematic review and meta-analysis. Tumour Biol 2014; 35: 7317-26.
7. Duran A, Linares JF, Galvez AS, Wikenheiser K, Flores JM, Diaz-Meco MT, Moscat J. The signaling adaptor p62 is an important NF-kappaB mediator in tumorigenesis. Cancer Cell 2008; 13: 343-54.
8. Seibenhener ML, Du Y, Diaz-Meco MT, Moscat J, Wooten MC, Wooten MW. A role for sequestosome 1/p62 in mitochondrial dynamics, import and genome integrity. Biochim Biophys Acta 2013; 1833: 452-9.
9. Travis WD. The 2015 WHO classification of lung tumors. Pathologe 2014; 35 Suppl 2: 188.
10. Li BX, Li CY, Peng RQ, Wu XJ, Wang HY, Wan DS, Zhu XF, Zhang XS. The expression of beclin 1 is associated with favorable prognosis in stage IIIB colon cancers. Autophagy 2009; 5: 303-6.
11. Park JM, Huang S, Wu TT, Foster NR, Sinicrope FA. Prognostic impact of Beclin 1, p62/sequestosome 1 and LC3 protein expression in colon carcinomas from patients receiving 5-fluorouracil as adjuvant chemotherapy. Cancer Biol Ther 2013; 14: 100-7.
12. Choi AM, Ryter SW, Levine B. Autophagy in human health and disease. N Engl J Med 2013; 368: 651-62.
13. Li Z, Chen B, Wu Y, Jin F, Xia Y, Liu X. Genetic and epigenetic silencing of the beclin 1 gene in sporadic breast tumors. BMC Cancer 2010; 10: 98.
14. Yao Q, Chen J, Lv Y, Wang T, Zhang J, Fan J, Wang L. The significance of expression of autophagy-related gene Beclin, Bcl-2, and Bax in breast cancer tissues. Tumour Biol 2011; 32: 1163-71.
15. Zhou WH, Tang F, Xu J, Wu X, Yang SB, Feng ZY, Ding YG, W-An XB, Guan Z, Li HG, Lin DJ, Shao CK, Liu Q. Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant ph-enotype and poor prognosis of gastric cancer. Autophagy 2012; 8: 389-400.
16. Zhao Y, Chen S, Gou WF, Xiao LJ, Takano Y, Zheng HC. Aberra-nt Beclin 1 expression is closely linked to carcinogenesis, different-iation, progression, and prognosis of ovarian epithelial carcinoma. Tumour Biol 2014; 35: 1955-64.
17. Wan XB, Fan XJ, Chen MY, Xiang J, Huang PY, Guo L, Wu XY, Xu J, Long ZJ, Zhao Y, Zhou WH, Mai HQ, Liu Q, Hong MH. Elevated Beclin 1 expression is correlated with HIF-1alpha in predicti-ng poor prognosis of nasopharyngeal carcinoma. Autophagy 2010; 6: 395-404.
18. Wei Y, Zou Z, Becker N, Anderson M, Sumpter R, Xiao G, Kinch L, Koduru P, Christudass CS, Veltri RW, Grishin NV, Peyton M, Minna J, Bhagat G, Levine B. EGFR-mediated Beclin 1 phosphoryla-tion in autophagy suppression, tumor progression, and tumor chemoresistance. Cell 2013; 154: 1269-84.
19. Wang RC, Wei Y, An Z, Zou Z, Xiao G, Bhagat G, White M, Rei-Chelt J, Levine B. Akt-mediated regulation of autophagy and tumor-igenesis through Beclin 1 phosphorylation. Science 2012; 338: 9.
20. Koneri K, Goi T, Hirono Y, Katayama K, Yamaguchi A. Beclin 1 g-ene inhibits tumor growth in colon cancer cell lines. Anticancer R-es 2007; 27: 1453-7.
21. Kim HP, Wang X, Chen ZH, Lee SJ, Huang MH, Wang Y, Ryter SW, Choi AM. Autophagic proteins regulate cigarette smoke-induced apoptosis: protective role of heme oxygenase-1. Autophagy 2008; 4: 887-95.
22. Mathew R, Karp CM, Beaudoin B, Vuong N, Chen G, Chen HY, Bray K, Reddy A, Bhanot G, Gelinas C, Dipaola RS, Karantza-Wadsworth V, White E. Autophagy suppresses tumorigenesis throu-gh elimination of p62. Cell 2009; 137: 1062-75.
23. Mohamed A, Ayman A, Deniece J, Wang T, Kovach C, Siddiqui MT, Cohen C. P62/Ubiquitin IHC Expression Correlated with Clinico-pathologic Parameters and Outcome in Gastrointestinal Carcinomas. Front Oncol 2015; 5: 70.
24. Giatromanolaki A, Sivridis E, Mendrinos S, Koutsopoulos AV, Kouk-Ourakis MI. Autophagy proteins in prostate cancer: relation with an-aerobic metabolism and Gleason score. Urol Oncol 2014; 32: e11-38.
25. Moscat J, Diaz-Meco MT. P62 at the crossroads of autophagy, ap-optosis, and cancer. Cell 2009; 137: 1001-4.
26. Linares JF, Amanchy R, Greis K, Diaz-Meco MT, Moscat J. Phosp-horylation of p62 bycdk1 controls the timely transit of cells throughmitosis and tumor cell proliferation. Mol Cell Biol 2011; 31: 105-17.